Well, well, upgrades already started, new studies to introduce products into the market asap, new collaborations with big pharma companies (Bayer) and waiting for a potential announcement of buyout will rocket the PPS of OncoMed other 50% today. Someone is with me?
My opinion is Aria will ask for a "label warining" and FDA will approve it, returning the PPS up to 20´s. Perhaps in one month (a Xmas gift!!)
I guess it already started, with more good news, other than insider investments and good projection, it could reach at least $5 this week and perhaps $6 by month end.
Tremor Video (NYSE: TRMR )
Given the booming popularity of online video, one would think that a company specializing in video advertising would be on top of the world. Unfortunately.
Tremor isn't profitable, and that's a concern, but analysts still see it bouncing back to grow revenue at an 18% clip next year. Another thing that makes Tremor attractive is that its June IPO finds it having nearly $2 per share in cash and equivalents on its balance sheet. That's a cushy mattress representing nearly half of Tremor's current market value, though naturally it will need to improve its cash flows to make that matter.
Based on the facts of products this company launched, the market/countries penetration, I guess Tremor soon could reach at least 6-7 PPS if not it will receive a buyout offer.
For me that is the reason of several insiders started to buy additional shares.
Ask Mr. Fred Hassan, reduce expenses and people in Pharmacia (Uphon) and then sold it to Pfizer, then reduce expenses and people in Shering and then sold it to Merck. Are we in front of same situtation???